Cytek Biosciences, Inc. (CTKB) stock
CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/309% below fair value
$5.92+0.22 (+3.86%)
Close on Nov 18, 2026Market cap $769.50MP/E –Yield –
Cytek Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Cytek Biosciences's price to sales ratio was 3.6× on Nov 11, 2026, against 3.7× a year earlier. Over the last 5 years it ranged from 1.8× to 22.5×, with a median of 4.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.6× | +0.3 |
| 2025 | Dec 31, 2025 | 3.3× | −0.9 |
| 2024 | Dec 31, 2024 | 4.2× | −2.6 |
| 2023 | Dec 29, 2023 | 6.8× | −2.2 |
| 2022 | Dec 30, 2022 | 8.9× | −9.3 |
| 2021 | Dec 31, 2021 | 18.2× | – |
See a number that looks wrong?